Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

他のバージョン（1件）を表示する

OBJECTIVES: Reports have suggested that a reduction in tumour 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) examination during or after neoadjuvant chemotherapy may predict pathological response in oesophageal cancer. Our aim was to determine whether metabolic response pr...

書誌詳細
主要な著者:	Gillies, R, Middleton, MR, Blesing, C, Patel, K, Warner, N, Marshall, R, Maynard, N, Bradley, K, Gleeson, F
フォーマット:	Journal article
言語:	English
出版事項:	2012

類似資料

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
著者:: Gillies, R, 等
出版事項: (2012)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
著者:: Findlay, J, 等
出版事項: (2017)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
著者:: Gillies, R, 等
出版事項: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
著者:: Gillies, R, 等
出版事項: (2012)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
著者:: Findlay, J, 等
出版事項: (2017)

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
著者:: Gillies, R, 等
出版事項: (2011)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
著者:: Gillies, R, 等
出版事項: (2011)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
著者:: Gillies, R, 等
出版事項: (2010)

Predicting pathological response of esophageal cancer to neoadjuvant chemotherapy: the implications of metabolic nodal response for personalised therapy
著者:: Findlay, J, 等
出版事項: (2016)

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
著者:: Teoh, S, 等
出版事項: (2016)

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
著者:: Chowdhury, F, 等
出版事項: (2008)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
著者:: Millo, J, 等
出版事項: (2003)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
著者:: Findlay, J, 等
出版事項: (2016)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
著者:: Rana, M, 等
出版事項: (2021)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
著者:: den Boer, RB, 等
出版事項: (2020)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
著者:: John M. Findlay, 等
出版事項: (2016-04-01)

A reply to evidence-based radiation oncology: oesophagus.
著者:: Gillies, R, 等
出版事項: (2010)

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
著者:: Kieran G. Foley, 等
出版事項: (2021-06-01)

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival
著者:: Teoh, S, 等
出版事項: (2018)

Assessment of Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Using MRI and 18F FDG PET/CT
著者:: Reem Yusuf AlBuainain, 等
出版事項: (2025-01-01)

Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
著者:: Tarik Sengoz, 等
出版事項: (2023-04-01)

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
著者:: Han Wonshik, 等
出版事項: (2011-10-01)

PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
著者:: Chowdhury, F, 等
出版事項: (2009)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
著者:: A. G. M. T. Powell, 等
出版事項: (2020-08-01)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
著者:: Alexander M Th Schmitz, 等
出版事項: (2017-01-01)

Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
著者:: Lihua Chen, 等
出版事項: (2017-08-01)

Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery
著者:: Findlay, J, 等
出版事項: (2019)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
著者:: Turkington, RC, 等
出版事項: (2019)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
著者:: M. K. Ibragimova, 等
出版事項: (2022-03-01)

Clinical value of SUVpeak-to-tumor centroid distance on FDG PET/CT for predicting neoadjuvant chemotherapy response in patients with breast cancer
著者:: Sun-pyo Hong, 等
出版事項: (2024-10-01)

Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
著者:: Sangwon Han, 等
出版事項: (2020-10-01)

Efficacy Of 18FDG-PET/CT In Predicting Response After Neoadjuvant Chemoradiation In Rectal Cancer
著者:: Narendra Pandit, 等
出版事項: (2023-08-01)

Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer
著者:: Inci Kizildag Yirgin, 等
出版事項: (2020-01-01)

The Role of Pretreatment 18F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
著者:: Yao J, 等
出版事項: (2021-10-01)

Predictors of complete response to neoadjuvant chemotherapy in non-metastatic bladder cancer
著者:: P. Sousa Passos, 等
出版事項: (2020-11-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy. Additional material
著者:: M. K. Ibragimova, 等
出版事項: (2022-03-01)

Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study
著者:: Rui-Qin Zhou, 等
出版事項: (2023-05-01)

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
著者:: Giulia Polverari, 等
出版事項: (2020-10-01)

Correlation Between 18F-FDG PET/CT SUVmax and Clinicopathological Features, Neoadjuvant Chemotherapy Response in Invasive Ductal Breast Carcinoma Patients
著者:: LU Shengnan, 等
出版事項: (2019-02-01)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
著者:: Willard Wong, 等
出版事項: (2021-07-01)